| Net (loss) income | -15.18M |
| Depreciation | 3.14M |
| Amortization of purchased intangibles | |
| Stock options | |
| Restricted stock units | |
| Tax benefit from other comprehensive income | -75K |
| Capitalization of mask set cost | |
| Net gain (loss) on disposals of property | |
| Accounts receivable | -4.29M |
| Inventories | 2.97M |
| Other assets | |
| Accounts payable | 384K |
| Accrued payroll and other accrued liabilities | |
| Deferred revenue | -10K |
| Net cash (used for) provided operating activities | 664K |
| Purchases of short-term investments | -28.8M |
| Proceeds from sales and maturities of short-term investments | 28.15M |
| Purchase of property and equipment | |
| Proceeds from sale of property and equipment | 2K |
| Purchases of strategic equity investment | |
| Proceeds from sale of strategic equity investment | |
| Funding of note receivable | |
| Net cash used for investing activities | -3.96M |
| Proceeds from issuance of common stock | 1.78M |
| Funding of restricted stock units withheld for taxes | |
| Repurchase of common stock | |
| Funding of structured stock repurchase agreements | |
| Funds received from structured stock repurchase agreements, including gains | |
| Other | |
| Net cash used for financing activities | 722K |
| Net decrease in cash and cash equivalents | -2.58M |
| Cash and cash equivalents at beginning of year | 25.07M |
| Cash and cash equivalents at end of year | 22.49M |
| Income taxes | 369K |